Cerus (CERS) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cerus | 549.42 Mn | 469.73 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.12% |
| Dec 31, 2025 | -8.95% |
| Sep 30, 2025 | -10.65% |
| Jun 30, 2025 | -13.28% |
| Mar 31, 2025 | -12.93% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -2.25% |
| Jun 30, 2024 | -5.18% |
| Mar 31, 2024 | -6.31% |
| Dec 31, 2023 | -8.76% |
| Sep 30, 2023 | -11.79% |
| Jun 30, 2023 | -10.59% |
| Mar 31, 2023 | -7.00% |
| Dec 31, 2022 | 11.98% |
| Sep 30, 2022 | 14.78% |
| Jun 30, 2022 | 14.33% |
| Mar 31, 2022 | 14.15% |
| Dec 31, 2021 | 8.18% |
| Sep 30, 2021 | 2.31% |
| Jun 30, 2021 | 2.45% |
| Mar 31, 2021 | 2.09% |
| Dec 31, 2020 | 1.84% |
| Sep 30, 2020 | 2.72% |
| Jun 30, 2020 | 0.71% |
| Mar 31, 2020 | 0.45% |
| Dec 31, 2019 | 6.56% |
| Sep 30, 2019 | 5.16% |
| Jun 30, 2019 | 8.22% |
| Mar 31, 2019 | 9.15% |
| Dec 31, 2018 | 14.58% |
| Sep 30, 2018 | 20.83% |
| Jun 30, 2018 | 10.48% |
| Mar 31, 2018 | 7.09% |
| Dec 31, 2017 | 15.30% |
| Sep 30, 2017 | 17.06% |
| Jun 30, 2017 | 16.23% |
| Mar 31, 2017 | 16.53% |
| Dec 31, 2016 | 25.84% |
| Sep 30, 2016 | 34.93% |
| Jun 30, 2016 | 41.31% |
| Dec 31, 2015 | 31.91% |